IDXX Stock Chart & Fundamental Analysis

Interactive Chart

About IDEXX Laboratories Inc

Name

IDEXX Laboratories Inc

CEO

Michael Erickson

Website

www.idexx.com

Industry

Healthcare

Year Founded

1983

Employees

11,000

IDEXX Laboratories, Inc. (NASDAQ: IDXX) develops diagnostic and information products for animal health and water testing within the medical diagnostics and research business, generating $4.3 billion in FY2025 revenue. Its work spans veterinary care, livestock and dairy monitoring, biomedical research support, and microbiological testing tools used in water quality programs worldwide.

Analyst Ratings

Consensus Recommendation

Buy1

Hold2

Sell5

Fundamentals & Financials

Revenue (TTM)

$4.5B

Net Income (TTM)

$1.1B

EPS (TTM)

$14.24

ROA (TTM)

33.11%

Current Ratio

1.17

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q2 FY2026	Q1 FY2026	Q4 FY2025
Revenue	$1,216.5M	$1,140.8M	$1,090.5M
Cost of Sales	$437,498K	$418,081K	$432,465K
Gross Profit	$779,087K	$722,739K	$658,114K
Operating Income	$425,566K	$362,586K	$315,605K
Net Income	$338,412K	$278,446K	$248,188K
EPS	$4.23	$3.48	$3.1

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

IDEXX Laboratories Inc's Technical Indicators Summary

IDXX presents a neutral technical profile marked by lackluster trend strength and mixed momentum readings. Price is trading below most short- and long-term moving averages including the 200-day, which tempers upside conviction, while stochastic measures show early buy signals and MACD is essentially flat. ADX indicates a weak trend and volume trends are not supportive, even as volatility remains moderate. The pivot sits just below the price, offering a nearby reference. Technical takeaway: neutral—balanced signals with short-term pickup offset by broader moving-average weakness.

Buy

1 signal

Neutral

2 signals

Sell

5 signals

Overall: Neutral25% Neutral signals

Indicator	Value	Signal	Explanation
RSI (14)	44.76	Neutral	RSI (44.76) is neutral.
Stochastic %K (14, 3, 3)	9.72	Buy	Stochastic (9.72) < 20, indicating oversold.
CCI (20)	-60.78	—	CCI (-60.78) is neutral.
WPR (14)	-82.41	—	Williams %R (-82.41) < -80, indicating oversold.
Momentum (10)	-34.77	—	Momentum (-34.77) is negative.
MFI	45.91	—	MFI (45.91) is neutral.
MACD Level (12, 26)	0.21	Neutral	Potential bearish reversal: MACD (0.21) crossed below signal but is still positive.
Bollinger Bands	$531.54 - $601.44	—	Price is within the bands.
ATR (14)	$19.15 (3.46%)	—	Moderate Volatility (3.46%).
ADX (14)	14.21	—	Weak or consolidating trend (ADX < 25). ADX(14.21), +DI(22.16), -DI(26.02)
OBV	6,424,029	—	Bearish volume pressure: OBV is below its 20-day SMA. OBV(6,424,029), 20D-SMA-OBV(6,632,094)
Classic Pivot Point	$546.89	—	Price ($553.32) is above the pivot ($546.89) but not yet breaking resistance R1 ($555.59) — mildly bullish / neutral zone.
Fibonacci Pivot Point	$546.89	—	Price ($553.32) is above the pivot ($546.89) but not yet breaking resistance R1 ($553.84) — mildly bullish / neutral zone.
Simple Moving Averages	$560.64 - $616.68(5 indicators)	—	SMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key SMA averages.
Exponential Moving Averages	$564.24 - $606.23(5 indicators)	Sell	EMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

IDXX inched higher in the last trading session, gaining a modest 1.32% to finish at 553.32. IDXX could be 22% undervalued as its new cardiac test expands its reach, signaling fresh upside.

Trading Volume

Below 10d avg (604.7K)

509K

vs S&P 500 Today

Outperforming Market

+2.01%

52-Week Position

Lower range

13.8%

Updated: August 19, 2026 at 12:33 UTC